Mylan Pharmaceuticals, Inc. (MYL) Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality
8/13/2009 9:08:58 AM
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Reports Adjusted Diluted EPS of $0.33 for the Quarter Ended March 31, 2009
4/30/2009 9:40:49 AM
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Seeks Tarceva and Lunesta Generic Approvals
3/26/2009 8:12:22 AM
More...
|
Cephalon, Inc. (CEPH) and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals, Inc. (MYL) and Barr Pharmaceuticals, Inc. (BRL)
11/26/2008 7:34:32 AM
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Acquires Remaining Interest in Somerset Pharmaceuticals Joint Venture From Watson Pharmaceuticals, Inc. (WPI) (JOBS)
7/29/2008 8:08:48 AM
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
7/28/2008 10:35:48 AM
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
7/3/2008 8:01:49 AM
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Wins Generic Prilosec(R) Patent Litigation Court of Appeals Affirms No Infringement
6/11/2008 9:26:39 AM
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Inks Supply Deal for Generic MS Drug
6/10/2008 7:18:57 AM
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Announces Final FDA Approval for Zaleplon Capsules
6/9/2008 11:29:49 AM
More...
|
|